Gene · 1672
Papers3,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single cell transcription revealing key transcription factors in embryonic kidney development. | Mol Cell Biochem | 2025 | 40392427 | PubTator, text mining | PubMed |
| Tumor budding and poorly differentiated clusters as a biological continuum in colorectal cancer invasion and prognosis. | Sci Rep | 2025 | 40374662 | PubTator, text mining | PubMed |
| Lysine-Targeting, Covalent Inhibitors of Bromodomain BD1 of BET Proteins in Live Cells and Animals. | Angew Chem Int Ed Engl | 2025 | 40313007 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of novel CDK4/6 and BRD4 dual inhibitors for treatment of KRAS-mutant NSCLC. | Eur J Med Chem | 2025 | 40311163 | PubTator, text mining | PubMed |
| Integrative genomic pan-cancer analysis reveals the prognostic significance of DEFB1 in tumors. | Discov Oncol | 2025 | 40244529 | PubTator, text mining | PubMed |
| Incorporation of human β-defensin-1 into immunoliposomes to facilitate targeted autophagy therapy of colon carcinoma. | World J Clin Oncol | 2025 | 40130061 | PubTator, text mining | PubMed |
| Macrocyclic dihydropyridine analogs as pan-BET BD2-preferred inhibitors. | Eur J Med Chem | 2025 | 40120495 | PubTator, text mining | PubMed |
| Design and development of a bright NIR fluorescent probe for selective HSA detection in human blood serum and urine. | Bioorg Chem | 2025 | 40086185 | PubTator, text mining | PubMed |
| Pioneering Clinical Investigation: Beta Defensin Expression in Patients of Squamous Cell Carcinoma of Oral Cavity as a Forward-Looking Validation for Molecular Treatment. | Indian J Otolaryngol Head Neck Surg | 2025 | 40070992 | PubTator, text mining | PubMed |
| HAS-CIRCpedia-5280 sponges miR-4712-5p inhibited colon cancer autophagyinduced by human beta-defensin-1. | J Transl Med | 2025 | 40050987 | PubTator, text mining | PubMed |
| Single cell transcriptomic analysis reveals tumor immune infiltration by macrophage cells gene signature in lung adenocarcinoma. | Discov Oncol | 2025 | 40029500 | PubTator, text mining | PubMed |
| Multi-Water Bridges Enable Design of BET BD1-Selective Inhibitors for Pancreatic Cancer Therapy. | J Med Chem | 2025 | 40011026 | PubTator, text mining | PubMed |
| Longitudinal Evaluation of Vitamin D, Parathyroid Hormone, Antimicrobial Peptides, and Immunomodulatory Genes in Hospitalized Foals. | J Vet Intern Med | 2025 | 40008921 | PubTator, text mining | PubMed |
| STANCE: a unified statistical model to detect cell-type-specific spatially variable genes in spatial transcriptomics. | Nat Commun | 2025 | 39979358 | PubTator, text mining | PubMed |
| Colorectal adenosquamous carcinoma: clinicopathologic analysis of two large cohorts and literature review confirm poor prognosis and reveal prognostic aspects. | Histopathology | 2025 | 39887413 | PubTator, text mining | PubMed |
| Design, Synthesis, and Biological Evaluation of Thieno[3,2-d]pyrimidine Derivatives as the First Bifunctional PI3Kδ Isoform Selective/Bromodomain and Extra-Terminal Inhibitors. | J Med Chem | 2025 | 39853339 | PubTator, text mining | PubMed |
| Design and Evaluation of Novel Selective BET BD2 Inhibitors by Combining QSAR, Molecular Docking and Molecular Dynamics Simulation Techniques. | Chem Biodivers | 2025 | 39835390 | PubTator, text mining | PubMed |
| Covalent Proximity Inducers. | Chem Rev | 2025 | 39692621 | PubTator, text mining | PubMed |
| Establishing a Ten Disulfidptosis-related Gene Signature for Prognostic Prediction in Skin Cutaneous Melanoma. | Comb Chem High Throughput Screen | 2025 | 38879775 | PubTator, text mining | PubMed |
| [A Case of Local Recurrence, Lymph Node Metastasis, Multiple Pulmonary Metastases and Multiple Hepatic Metastases following EMR for T1a Rectal Cancer]. | Gan To Kagaku Ryoho | 2024 | 39948929 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1672/papers?page=6